ITEK


Piper Jaffray Moves to the Sidelines and Slashes Price Target on Inotek Pharmaceuticals Corp (ITEK); Shares Crash 70%

Inotek Pharmaceuticals Corp (NASDAQ:ITEK) shares are on a rapid 70% descent after the firm announced top-line results this morning from the Phase 3 …

Piper Jaffray Pounds The Table On Inotek Pharmaceuticals Corp (ITEK)

Piper Jaffray analyst Joshua Schimmer was out pounding the table on Inotek Pharmaceuticals Corp (NASDAQ:ITEK) Tuesday, reiterating an Overweight rating and raising the price target from $9 to $29, …

Canaccord Raises Price Target for Inotek Pharmaceuticals Corp (ITEK) as FDA Greenlights Trabodenoson Phase 3 Design

Inotek Pharmaceuticals Corp (NASDAQ:ITEK) shares are up 10.67% to $17.

IPO Preview: Inotek Pharmaceuticals

Based in Lexington, MA, Inotek Pharmaceuticals (Pending:ITEK)scheduled a $65 million IPO on Nasdaq, with a market capitalization of $191 million, at a price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts